PLoS ONE (Jan 2023)

RNA-seq RNAaccess identified as the preferred method for gene expression analysis of low quality FFPE samples.

  • Kai Song,
  • Emon Elboudwarej,
  • Xi Zhao,
  • Luting Zhuo,
  • David Pan,
  • Jinfeng Liu,
  • Carrie Brachmann,
  • Scott D Patterson,
  • Oh Kyu Yoon,
  • Marianna Zavodovskaya

DOI
https://doi.org/10.1371/journal.pone.0293400
Journal volume & issue
Vol. 18, no. 10
p. e0293400

Abstract

Read online

Clinical tumor tissues that are preserved as formalin-fixed paraffin-embedded (FFPE) samples result in extensive cross-linking, fragmentation, and chemical modification of RNA, posing significant challenges for RNA-seq-based gene expression profiling. This study sought to define an optimal RNA-seq protocol for FFPE samples. We employed a common RNA extraction method and then compared RNA-seq library preparation protocols including RNAaccess, RiboZero and PolyA in terms of sequencing quality and concordance of gene expression using FFPE and case-matched fresh-frozen (FF) triple-negative breast cancer (TNBC) tissues. We found that RNAaccess, a method based on exome capture, produced the most concordant results. Applying RNAaccess to FFPE gastric cancer tissues, we established a minimum RNA DV200 requirement of 10% and a RNA input amount of 10ng that generated highly reproducible gene expression data. Lastly, we demonstrated that RNAaccess and NanoString platforms produced highly concordant expression profiles from FFPE samples for shared genes; however, RNA-seq may be preferred for clinical biomarker discovery work because of the broader coverage of the transcriptome. Taken together, these results support the selection of RNA-seq RNAaccess method for gene expression profiling of FFPE samples. The minimum requirements for RNA quality and input established here may allow for inclusion of clinical FFPE samples of sub-optimal quality in gene expression analyses and ultimately increasing the statistical power of such analyses.